Gennex Laboratories Ltd

BSE: 531739

40

total announcements

GENNEX.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 15 Oct 2026

Market Cap

₹229 Cr

P/E (TTM)

12.2

EPS (TTM)

₹0.77

52W Low

₹7.05

52W High

₹17.25

Dividend Yield

0.00%

Beta

1.06

Price / Book

1.0

Debt / Equity

34.1

Revenue (TTM)

₹178 Cr

Gross Margin

23.79%

Operating Margin

9.56%

Announcements Discussion

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Genex Laboratories Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed the BSE about the cessation of a non-executive independent director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed the BSE about the cessation of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed BSE about the cessation of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed the BSE about the cessation of a non-executive independent director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

GENNEX LABORATORIES LIMITED

GENNEX LABORATORIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Gennex Laboratories Limited has informed BSE about the appointment of a Non-Executive Independent Director.

BSECompany UpdateMgmt Change30 Sept 2026

Gennex Laboratories Ltd

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has received approval of its members by Special Resolution passed in the 41st AGM of the Company held on September 30, 2026 for appointment of Mr. Dipankar Dasgupta as Independent Non-Executive Director of the Company with effect from October 01, 2026 in place of retiring Independent Non Executive Director Mr. ....

Gennex Laboratories Ltd has announced the appointment of Mr. Dipankar Dasgupta as an Independent Non-Executive Director, replacing Mr. Amudala Sreeramulu Nageswar Rao, with effect from October 1, 2026.

Read more →📎 1 attachment

BSEAGM/EGM30 Sept 2026

Gennex Laboratories Ltd

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday, September 30, 2026 through VC and OAVM. The meeting was held in compliance to the General Circular no. 03/2025 dated September 22, 2025 issued by MCA and Circular no. 2024/133 dated October 03, 2024 issued by SEBI, Companies are allowed to hold AGM through VC and OAVM without the physical presence ....

Gennex Laboratories Ltd held its 41st eAGM on September 30, 2026, through video conferencing, with 47 members in attendance. The meeting was conducted in compliance with SEBI and MCA guidelines. The company's directors and other representatives attended the meeting, and e-voting was enabled for members to cast their votes.

Read more →📎 1 attachment

BSEInsider Trading / SASTResults22 Sept 2026

Gennex Laboratories Ltd

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of he Company shall remained closed from October 01, 2026 till 48 hours after the Public announcement through Board of Directors in their meeting held for announcing the Unaudited Standalone and Consolidated Financial Results for the ....

Gennex Laboratories Ltd has announced the closure of its trading window from October 01, 2026, until 48 hours after the public announcement of its unaudited standalone and consolidated financial results for the second quarter and half-year ended on September 30, 2026.

Read more →📎 1 attachment

BSEBoard Meeting27 Aug 2026

Gennex Laboratories Ltd

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve 1. To decide regarding ....

Gennex Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 to consider and approve the conduct of 41st AGM for the year ended March 31, 2026, and other matters.

Read more →📎 1 attachment

BSECompany UpdateResults17 Aug 2026

Gennex Laboratories Ltd

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter ....

Gennex Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with total income from operations at ₹3,667.49 crore and profit after tax at ₹305.53 crore.

Read more →📎 1 attachment

BSEResultResults14 Aug 2026

Gennex Laboratories Ltd

In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended ....

Gennex Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 395.53 lakhs and a total comprehensive income of Rs. 395.53 lakhs.

Read more →📎 1 attachment

BSEBoard MeetingResults14 Aug 2026

Gennex Laboratories Ltd

In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ....

Gennex Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 395.53 lakhs. The company's total income was Rs. 3,667.49 lakhs, with expenses totaling Rs. 3,246.96 lakhs. The results have been reviewed by the Audit Committee and approved by the Board of Directors.

Read more →📎 1 attachment

BSECompany UpdateResults30 Jul 2026

Gennex Laboratories Ltd

Pursuant to Regulation 47 of SEBI (LODR), Regulations, 2015, please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to ....

Gennex Laboratories Ltd has announced that its Board of Directors will meet on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The meeting is in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment

BSEBoard MeetingResults29 Jul 2026

Gennex Laboratories Ltd

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Unaudited Financial ....

Gennex Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve the Unaudited Financial Statements for the Quarter ended June 30, 2026.

Read more →📎 1 attachment

BSEInsider Trading / SAST23 Jun 2026

Gennex Laboratories Ltd

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window ....

Gennex Laboratories Ltd has announced the closure of its trading window for insiders from July 01, 2026, until 48 hours after the public announcement of its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The date for the Board Meeting to approve these results will be intimated in due course.

Read more →📎 1 attachment

← PreviousPage 2 of 2